---
$id: https://graph.org.ai/products/commodity/51372040
$type: Product
source: UNSPSC
code: "51372040"
title: "Nalbuphine hydrochloride"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nalbuphine hydrochloride

**UNSPSC Code**: 51372040
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid with the molecular formula C21H27NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZU4275277R, chemically known as 17-(cyclobutylmethyl)-4,5alpha-epoxymorphinan-3,6alpha,14-triol hydrochloride but more generally known as nalbuphine hydrochloride, which bears US NIH Compound Identifier 5360733. European Medicines Agency schedules Nalbuphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14626MIG. Most nations, for tariff and trade purposes, schedule nalbuphine hydrochloride under HS 29391900 and SITC 54141. As of Q4 2014, NALBUPHINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Nalbuphine hydrochloride bears US NLM identifiers UMLS ID C0600099 and NCI Concept Code C47629. SMILES: C1CC(C2C3C1C[C@@H]4[C@]5([C@]3(CCN4CC6CCC6)[C@@H](O2)[C@H](CC5)O)O)O.CL.

